晚期病患者患者决策辅助器的有效性:基于随机对照试验的元分析
Yingjie Leng1, Tao Li1, Ruonan Xie1
1College of Nursing, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, Sichuan Provence, China.
International urology and nephrology
|June 11, 2024
概括
患者决策辅助器 (PtDAs) 显著改善了晚期慢性病患者的决策知识和准备. 这些工具还可以减少决策后悔和冲突,在医疗保健旅程中赋予患者权力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 医疗决策的制定 医疗决策的制定
- 卫生科学 卫生科学 卫生科学
背景情况:
- 晚期慢性病 (CKD) 提出了复杂的治疗选择.
- 有效的决策对于管理晚期CKD的患者至关重要.
- 患者决策辅助器 (PtDAs) 提供了一个结构化的方法来支持这些决策.
研究的目的:
- 系统地评估患者决策辅助工具 (PtDA) 的有效性.
- 评估PtDAs对晚期慢性病患者的决策过程的影响.
主要方法:
- 一个系统的审查和11个随机对照试验的元分析.
- 包括1613名患有晚期慢性病的患者.
- 使用RevMan 5.2和Cochrane 5.1.0质量评估提取和分析数据.
主要成果:
- PtDAs显著提高了决策知识 (SMD = 0.53,P = 0.0002).
- PtDAs 增强了决策准备 (SMD = 2.34,P < 0.00001).
- PtDAs 减少了决策后悔 (SMD = -1.33,P < 0.05) 和决策冲突 (SMD = -0.88,P = 0.004) 的发生.
结论:
- 患者决策辅助工具是晚期慢性病患者的有效工具.
- PtDAs提高了患者对治疗决策的理解和准备.
- 在晚期CKD患者的决策中,PtDAs有助于降低遗憾和冲突的水平.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
84
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
84
Renal Failure: Dose Adjustments
84
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
84
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
Dialysis
293
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
293
Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
Antihypertensive Drugs: Direct Renin Inhibitors
585
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
585


